Tumour budding in invasive breast carcinoma and its correlation with histopathological prognostic parameters and hormone receptor status

被引:2
|
作者
Kundu, Tamanna [1 ]
Giri, Ranjana [1 ]
Hota, Subhransu K. [1 ]
Sahu, Subrat K. [2 ]
Senapati, Urmila [1 ]
机构
[1] KIIT Univ, Dept Pathol, Kalinga Inst Med Sci, Bhubaneswar, Odisha, India
[2] KIIT Univ, Dept Oncosurg, Kalinga Inst Med Sci, Bhubaneswar, Odisha, India
关键词
Breast carcinoma; pan cytokeratin; tumor budding;
D O I
10.4103/jcrt.jcrt_656_22
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Tumor Budding (TB) is emerging as an important sensitive indicator of aggressiveness over traditional histopathological variables such as lymph node metastasis and lymphovascular invasion because TB at the invasive front was postulated as the first step of invasion and metastasis. But the role of TB in breast carcinoma is not yet standardized. Aim: This study aims to assess the prognostic significance of TB in breast carcinoma. Objectives: To study and grade TB in invasive breast carcinoma and correlate it with known histopathological prognostic markers and hormone receptor status. Materials and Methods: In this ambispective study, 51 cases of invasive breast carcinoma undergoing radical surgery were studied from September 2017 to September 2021. Tumor buds were defined as a single or cluster of up to four tumor cells at the invasive front of the tumor and were counted by using IHC Pancytokeratin in 200X and graded into a three-tier grading system. The correlation between TB with established histopathological parameters and hormone receptor status was studied. A Chi-square test was used and a P value < 0.05 was considered significant. Results: TB was seen in all cases of invasive breast carcinoma. Grade 1 TB was seen in 37.26% (19/51) of cases and Grade 2 TB and Grade 3 TB in 31.37% (16/51) of cases each. There was a lack of significant correlation between TB with histologic grade, lymph node status, and HER2 neu. Correlation between TB with Estrogen receptor (ER), Progesterone receptor (PR), and American Joint Committee on Cancer (AJCC) Prognostic stage group was noted but it was not statistically significant. Conclusion: Although several studies have confirmed the prognostic value of TB in breast carcinoma, they had used several different methods of assessment. So, there is a need for a standardized method for the assessment of TB in breast carcinoma. Further standardization of TB may add its value as a prognostic factor.
引用
收藏
页码:S664 / S668
页数:5
相关论文
共 50 条
  • [21] Estrogen receptorβ status in invasive carcinoma of breast
    Belanger, E
    Fanella, S
    Verma, S
    Robertson, SJ
    LABORATORY INVESTIGATION, 2002, 82 (01) : 28A - 28A
  • [22] STUDY OF HORMONE RECEPTOR STATUS IN CARCINOMA BREAST
    Somani, Kiran
    Kansal, Abhishek
    Singh, Raghvendra
    Patel, Akhilesh
    Datey, Sanjay
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2018, 7 (38): : 4988 - 4991
  • [23] The histopathological and molecular features of breast carcinoma with tumour budding—a systematic review and meta-analysis
    Angus J. Lloyd
    Éanna J. Ryan
    Michael R. Boland
    Sami Abd Elwahab
    Carmel Malone
    Karl J. Sweeney
    Kevin M. Barry
    Raymond McLaughlin
    Michael J. Kerin
    Aoife J. Lowery
    Breast Cancer Research and Treatment, 2020, 183 : 503 - 514
  • [24] Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma
    Chen, WY
    Hankinson, SE
    Schnitt, SJ
    Rosner, BA
    Holmes, MD
    Colditz, GA
    CANCER, 2004, 101 (07) : 1490 - 1500
  • [25] Vimentin expression in invasive ductal carcinoma of the breast is associated with hormone receptor status.
    Bloom, K
    Baunoch, D
    Moore, M
    Reyes, M
    Stahl, R
    Husam, H
    Ma, XJ
    Sgroi, D
    Erlander, M
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S75 - S75
  • [26] Comparison of Cytological versus Histopathological Grading of Invasive Ductal Carcinoma of the Breast with Correlation of Lymph Node Status
    Ravikumar, Gayatri
    Rout, Pritilata
    MIDDLE EAST JOURNAL OF CANCER, 2015, 6 (02)
  • [27] Accuracy of cytological grading in the carcinoma breast and its correlation with pathological prognostic parameters
    Chauhan, Devika
    Sahu, Nageswar
    Sahoo, Saroj R.
    Senapati, Urmila
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (07) : 1956 - 1961
  • [28] Clinical and Histopathological Tumour Characteristics in Patients With Invasive Breast Carcinoma Receiving Metformin
    Rok, P.
    Satej, N.
    Marinko, T.
    Horvat, A. Gojkovic
    Ratosa, I.
    Lukancic, M. Mori
    Gazic, B.
    Besic, N.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S364 - S364
  • [29] The Expression of Cytokeratin 19 in Breast Carcinoma and Its Association with Hormone Receptor Status
    Aardsma, N. A.
    Groth, J. V.
    Prabhu, S. V.
    Wiley, E. L.
    MODERN PATHOLOGY, 2013, 26 : 25A - 25A
  • [30] The Expression of Cytokeratin 19 in Breast Carcinoma and Its Association with Hormone Receptor Status
    Aardsma, N. A.
    Groth, J. V.
    Prabhu, S. V.
    Wiley, E. L.
    LABORATORY INVESTIGATION, 2013, 93 : 25A - 25A